MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-01-0016461
Brichem Sciences Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹91.35 Cr
▲ 16% YoY
Net profit · FY 2025
₹7.67 Cr
Net margin 8.4%
EBITDA · FY 2025
₹12.2 Cr
EBITDA margin 13.4%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹13.5 Lakh
Issued & subscribed
Open charges
₹12.3 Cr
Satisfied ₹19.2 Cr
Company age
10 yrs
Est. 2016
Employees · EPFO
88
Provident fund records
About Brichem Sciences Private Limited
Data last updated:
Brichem Sciences Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 05 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2016PTC094569. Its GSTIN is 24AAGCB9892E2ZE (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹13.5 Lakh. It is led by directors including Rajeshkumar Becharbhai Gami and Paragkumar Gunvantlal Bhavsar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Block A Shop 114 Ganesh Meridian Opp. High Court S G Highway Ghatlodia, Ahmedabad, Gujarat, India – 380061.
As per the financials filed for FY 2025, the company reported a revenue of ₹91.35 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹7.67 Cr (net margin 8.4%) and EBITDA of ₹12.2 Cr (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 52% over five years.
The company has about 88 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Brichem Sciences. As per MCA filings, the company has open charges of ₹12.3 Cr and satisfied charges of ₹19.2 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending. The company has 6 deals on record (5 secondary share transfers, 1 rights issue); the latest was in March 2023. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Polypeptide Laboratories Private Limited with revenue of ₹94.1 Cr. The company has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 27 overdue payments to 9 micro and small suppliers.
Brichem Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0016461). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brichemsciences.com.
Company details
CIN U24304GJ2016PTC094569
Registration Number 094569
Incorporation Date 05 December 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-01-0016461
Key People
Rajeshkumar Becharbhai Gami Director Paragkumar Gunvantlal Bhavsar Director Aashay Jayantilal Patel Director Recognitions & Rankings of Brichem Sciences
Contact details
Brichem Sciences Private Limited's registered office is in Ahmedabad, Gujarat. Its website is brichemsciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBlock A Shop 114 Ganesh Meridian Opp. High Court S G Highway Ghatlodia, Ahmedabad, Gujarat, India – 380061
- IndustryPharma, API Manufacturers
To see the full contact details of Brichem Sciences Private Limited, buy the company report.
Comprehensive company report
Brichem Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Brichem Sciences operates one associated brand: Brichem Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Brichem Sciences produces API, hormones, and steroids for pharmaceutical industry. | brichemsciences.com |
Business activity
The main business activity of Brichem Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brichem Sciences Private Limited, buy the company report.
Financials of Brichem Sciences Private Limited
FY 2024 filings availableBrichem Sciences Private Limited reported revenue of ₹91.35 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹91.35 Cr ▲ 16%
Net profit · FY 2025
₹7.67 Cr margin 8.4%
EBITDA · FY 2025
₹12.2 Cr margin 13.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 27%
5 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 58%
5 years · compounded
▲ 61%
Revenue has grown at a compounded annual rate (CAGR) of 52% over five years, including 16% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.67 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | ||||
| Net Profit Margin | 8.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brichem Sciences Private Limited, buy the company report.
Board of directors of Brichem Sciences Private Limited
Brichem Sciences has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeshkumar Becharbhai Gami Also directs: Sarvtra Lifesciences LLP, Aurum Legacy Owners Service Association | Director | 05 Dec 2016 | 9 Years 10 Months | Current |
| Paragkumar Gunvantlal Bhavsar Also directs: Ticop Life Private Limited, Maharshi Pharma Chem Private Limited, Palam Life Sciences Private Limited and 2 more | Director | 23 Mar 2019 | 7 Years 7 Months | Current |
| Aashay Jayantilal Patel Also directs: Maharshi Pharma Chem Private Limited, Vidman Pharmaceuticals Private Limited, Someshwar Ispat Private Limited and 1 more | Director | 31 Jul 2019 | 7 Years 2 Months | Current |
| Mittalkumar Jagdishbhai Patel | Director | 31 Jul 2019 | 7 Years 2 Months | Current |
Peer comparison
Brichem Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Polypeptide Laboratories Private Limited | ₹94.1 Cr (FY 2025) | 34.0% | Ambernath, Maharashtra, India | |||
| Integrin Lifesciences Private Limited | ₹92.04 Cr (FY 2025) | 3.0% | Hyderabad, Telangana, India | |||
| Gennex Laboratories Limited | ₹91.62 Cr (FY 2024) | 32.0% | Medak, Telangana, India | |||
| Brichem Sciences Private Limitedthis company | ₹91.35 Cr (FY 2025) | ₹7.67 Cr | 8.4% | 16.0% | 88 | Ahmedabad, Gujarat, India |
| Modepro (India) Pvt Ltd | ₹91.12 Cr (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| Pab Organics Private Limited | ₹90.32 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India | |||
| Verdant Life Sciences Private Limited | ₹89.48 Cr (FY 2025) | 6.0% | Andhra Pradesh, India | |||
| Medilux Laboratories Pvt Ltd | ₹89.42 Cr (FY 2018) | -2.0% | Indore, Madhya Pradesh, India | |||
| Tagoor Chemicals Private Limited | ₹88.93 Cr (FY 2021) | 15.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Brichem Sciences Private Limited, buy the company report.
Auditor
Brichem Sciences Private Limited is audited by KEYUR KARWA & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KEYUR KARWA & CO | FY 2024 | 148927W |
Shareholding
The shareholding of Brichem Sciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Brichem Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.3 Cr
Satisfied charges
₹19.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Feb 2024 | 100882043 | Others | ₹12.3 Cr | Open | |
| 10 Sep 2019 | 100298876 | Others | ₹18.4 Cr | Satisfied | |
| 09 Feb 2018 | 100153818 | The Kalupur Commercial Co-Operative Bank Limited | ₹80 Lakh | Satisfied |
To see the full charge records of Brichem Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Brichem Sciences Private Limited has 6 deals on record (5 secondary share transfers, 1 rights issue); the latest was in March 2023.
Total deals
6
Secondary share transfers
5
Rights issue
1
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Dec 2019 | Rights issue | ₹1.88 Cr | Investors: 4 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Dec 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 4 individuals |
To see the full deal history of Brichem Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Brichem Sciences Private Limited has 4 court cases on record: 4 filed by Brichem Sciences. 2 cases are pending and 2 are disposed.
Total cases
4
Filed by the company
4
Pending
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Triglobal Life Science Pvt Ltd and 1 other | Pending |
| District court, Ahmedabad, Gujarat | Court case (CMA SC) | Filed by the company against individuals | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against Triglobal Life Science Pvt Ltd and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed by the company against individuals | Disposed |
To see the full case history of Brichem Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Brichem Sciences Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 27 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Credence Chem Private Limited | |||
| Novaphene Specialities Private Limited | |||
| Sagar Chemicals | |||
| an individual supplier | |||
| Scientific Sales Research Chemicals Private Limited |
To see the full MSME payment records of Brichem Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Brichem Sciences Private Limited has a workforce of 88 employees on its EPFO records as of Feb 24, 2025, across 1 active EPFO establishment.
Employee count
88
Active EPFO establishments
1
Employee growth
10%
GST
Brichem Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCB9892E2ZE | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Brichem Sciences Private Limited, buy the company report.
Recent activity
Brichem Sciences Private Limited has 10 board changes on record since 2016: 4 appointments and 6 cessations. The latest: Aashay Jayantilal Patel ceased to be Additional Director on 28 Sep 2019.
Charges
A charge with Others of Rs. 1,230.00 Lakh registered on 22 Feb 2024 with Charge ID 100882043 was modified on 13 Aug 2025.
AGM
Brichem Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Brichem Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge registered on 10 Sep 2019 via Charge ID 100298876 with Others was fully satisfied on 26 Feb 2024.
Charges
A charge with Others amounted to Rs. 1,230.00 Lakh with Charge ID 100882043 was registered on 22 Feb 2024.
Charges
A charge with Others of Rs. 1,840.00 Lakh registered on 10 Sep 2019 with Charge ID 100298876 was modified on 14 Apr 2021.
Ceased
Aashay Jayantilal Patel ceased to be Additional Director.
Ceased
Mittalkumar Jagdishbhai Patel ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 1,840.00 Lakh with Charge ID 100298876 was registered on 10 Sep 2019.
Appointed
Aashay Jayantilal Patel was appointed as Director.
Appointed
Mittalkumar Jagdishbhai Patel was appointed as Director.
Charges
A charge registered on 09 Feb 2018 via Charge ID 100153818 with The Kalupur Commercial Co-Operative Bank Limited was fully satisfied on 12 Jul 2019.
8 earlier events are in the company report.
Frequently asked questions
Brichem Sciences is an active private limited company based in Ahmedabad, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 05 December 2016 (10+ years old) and is registered under CIN U24304GJ2016PTC094569.
Brichem Sciences has 4 current directors:
- Rajeshkumar Becharbhai Gami - Director
- Paragkumar Gunvantlal Bhavsar - Director
- Aashay Jayantilal Patel - Director
- Mittalkumar Jagdishbhai Patel - Director
The latest financial statements of Brichem Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Brichem Sciences is 24AAGCB9892E2ZE, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Brichem Sciences is U24304GJ2016PTC094569. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brichem Sciences has 4 court cases on record: 4 filed by the company. 2 are pending.
Brichem Sciences was incorporated on 05 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Brichem Sciences has 6 deals on record (5 secondary share transfers, 1 rights issue); the latest was in March 2023.
The peers of Brichem Sciences by revenue are Polypeptide Laboratories Private Limited, Integrin Lifesciences Private Limited, Gennex Laboratories Limited, Modepro (India) Pvt Ltd, Pab Organics Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aashay Jayantilal Patel ceased to be Additional Director on 28 Sep 2019. Mittalkumar Jagdishbhai Patel ceased to be Additional Director on 28 Sep 2019. Aashay Jayantilal Patel was appointed as Director on 31 Jul 2019. Brichem Sciences has 10 board changes on record in total.
Yes, Brichem Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-01-0016461).
Brichem Sciences has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 27 overdue payments to 9 micro and small suppliers. The latest return was filed on 30 Oct 2021.